Format

Send to

Choose Destination
Complement Ther Med. 2016 Aug;27:65-7. doi: 10.1016/j.ctim.2016.06.001. Epub 2016 Jun 7.

Re-analysis of survival data of cancer patients utilizing additive homeopathy.

Author information

1
Medical University of Vienna, Center for Medical Statistics, Informatics, and Intelligent Systems, Vienna, Austria.
2
Medical University of Vienna, Dept. Medicine I, Division of Oncology, Vienna, Austria.
3
Medical University of Vienna, Dept. Medicine I, Division of Oncology, Vienna, Austria; University of Berne, Institute for Complementary Medicine, Bern, Switzerland. Electronic address: katharina.gaertner@ikom.unibe.ch.

Abstract

In this short communication we present a re-analysis of homeopathic patient data in comparison to control patient data from the same OutpatientĀ“s Unit "Homeopathy in malignant diseases" of the Medical University of Vienna. In this analysis we took account of a probable immortal time bias. For patients suffering from advanced stages of cancer and surviving the first 6 or 12 months after diagnosis, respectively, the results show that utilizing homeopathy gives a statistically significant (p<0.001) advantage over control patients regarding survival time. In conclusion, bearing in mind all limitations, the results of this retrospective study suggest that patients with advanced stages of cancer might benefit from additional homeopathic treatment until a survival time of up to 12 months after diagnosis.

KEYWORDS:

Additive homeopathy; Cancer; Immortal time bias; Landmark

PMID:
27515878
DOI:
10.1016/j.ctim.2016.06.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center